Focuses on process-level discovery and optimization of peptide therapeutics: macrocyclic scaffolds and peptide–drug conjugates for GPCRs, stabilized modulators of immune cell migration, and immunoenhancers. Integrates peptidomics and 3D mass spectrometry imaging with clinical proteomics to link mechanisms to disease.